A detailed history of Scientech Research LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Scientech Research LLC holds 11,371 shares of TMDX stock, worth $893,533. This represents 0.36% of its overall portfolio holdings.

Number of Shares
11,371
Previous 12,767 10.93%
Holding current value
$893,533
Previous $1.92 Billion 7.16%
% of portfolio
0.36%
Previous 0.4%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$135.68 - $176.11 $189,409 - $245,849
-1,396 Reduced 10.93%
11,371 $1.79 Billion
Q2 2024

Aug 14, 2024

BUY
$72.62 - $150.62 $927,139 - $1.92 Million
12,767 New
12,767 $1.92 Billion

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.5B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Scientech Research LLC Portfolio

Follow Scientech Research LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scientech Research LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scientech Research LLC with notifications on news.